- Short Stature in a Boy with Multiple Early-Onset Autoimmune Conditions due to a STAT3 Activating Mutation: Could Intracellular Growth Hormone Signalling Be Compromised?2017 | Second Faculty of Medicine
- Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome2015 | Second Faculty of Medicine
- An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia2017 | First Faculty of Medicine, Second Faculty of Medicine
- An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia2017 | Central Library of Charles University
- Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes2004 | Second Faculty of Medicine
- Gefitinib monotherapy in advanced non-small cell lung cancer harboring activating mutation of EGFR had significantly better treatment results comparing to standard chemotherapy - from clinical practice2010 | First Faculty of Medicine
- Neonatal Diabetes Mellitus Caused by Activation Mutation in the Gene Encoding the Kir6.2 Subunit of Potassium Channel: Is Insulindependency Inevitably Life-long?2005 | First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Interdisciplinary consensus for predictive testing of activation mutations of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer2011 | Central Library of Charles University, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells2010 | Central Library of Charles University
- Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study2018 | Second Faculty of Medicine
- Management of advanced non-small cell lung cancer +12015 | First Faculty of Medicine
- Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study2016 | Second Faculty of Medicine
- Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH12007 | Central Library of Charles University
- Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: A large patient cohort study2017 | Second Faculty of Medicine
- Milecular diagnosis of EGFR gene mutations for biological therapy with tyrosine kinase inhibitors in patients with non-small-cell ung cancer.2010 | First Faculty of Medicine
- Neonatal Tyreoxicosis2001 | Third Faculty of Medicine
- McCune Albright syndrome and bilateral adrenal hyperplasia: the GNAS mutation may only be present in adrenal tissue2015 | Second Faculty of Medicine
- Significance of RAS testing in colorectal cancer2015 | First Faculty of Medicine
- Sulphonylurea treatment does not improve psychomotor development in children with KCNJ11 mutations causing permanent neonatal diabetes mellitus accompanied by developmental delay and epilepsy (DEND syndrome)2007 | Second Faculty of Medicine
- Non-clear cell renal cell carcinoma: novel treatments2022 | First Faculty of Medicine
- Trifluridine/tipiracil treatment in a patient with mucinous metastatic colorectal carcinoma2022 | Third Faculty of Medicine
- Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs2017 | Second Faculty of Medicine
- Afatinib - clinical practice experience2018 | Second Faculty of Medicine
- Advances in Clinical Treatment of Malignant Melanoma: B-RAF Kinase Inhibition2011 | Third Faculty of Medicine
- Gastrointestinal stromal tumor molecular diagnostics in relation to the prediction of a therapeutic response to targeted biological therapy2011 | Second Faculty of Medicine
- Retreatment with erlotinib of a patient with metastatic NSCLC harboring EGFR mutation: a case report2014 | Faculty of Medicine in Pilsen
- Afatinib - drug profile2017 | Publication without faculty affiliation
- Indication of EGFR Kinase Inhibitors Should Be Refined2011 | Third Faculty of Medicine
- Molecular pathology of pulmonary carcinomas2014 | Third Faculty of Medicine